Verition Fund Management
PRME icon

Verition Fund Management’s Prime Medicine PRME Stock Holding History

Verition Fund Management’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-290,983
Closed -$1.01M – 3272
2025
Q4 		$1.01M Buy
+290,983
New +$1.29M ﹤0.01% 2152
2025
Q2 		– Sell
-38,255
Closed -$76.1K – 3809
2025
Q1 		$76.1K Sell
38,255
-65,290
-63% -$167K ﹤0.01% 3177
2024
Q4 		$302K Buy
103,545
+65,000
+169% +$228K ﹤0.01% 2777
2024
Q3 		$149K Buy
+38,545
New +$179K ﹤0.01% 2946
2024
Q2 		– Sell
-29,515
Closed -$207K – 3212
2024
Q1 		$207K Buy
+29,515
New +$224K ﹤0.01% 2484

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Verition Fund Management's PRME Position: Q1 2026 in Review

Verition Fund Management sold out of Prime Medicine (PRME) in Q1 2026, closing a stake of 290,983 shares — an estimated $1.01M sold.

Verition Fund Management first reported a position in PRME in Q1 2024 and held it in 5 quarters. The position peaked at $1.01M in Q4 2025. 192 funds tracked by Wall St. Rank hold PRME as of Q1 2026.

  • Verition Fund Management reported no remaining Prime Medicine position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 290,983 Prime Medicine shares in Q1 2026, an estimated $1.01M.
  • Verition Fund Management first reported a position in Prime Medicine in Q1 2024 and held it in 5 quarters.
  • Verition Fund Management's Prime Medicine position peaked at $1.01M in Q4 2025.
  • 192 funds tracked by Wall St. Rank held Prime Medicine as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.